Gene test could make painkillers safer for elderly surgery patients
NCT ID NCT07484867
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a gene called CYP2D6 influences pain relief from the drug oxycodone in 100 older adults (age 60+) having lung cancer surgery. Researchers measured pain and sedation levels to see if genetic differences affect how well the drug works and how safe it is. The goal is to help doctors choose the right dose for each patient, reducing side effects and improving pain control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Henan Provincial People's Hospital
Zhengzhou, Henan, 450000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Electric pulses on the wrist may tame colonoscopy pain
- Virtual reality may distract patients from pain and fear during anesthesia
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Could a gentle yoga practice turn down the Body's pain and inflammation?